Oncotelic Therapeutics
Why Robinhood?
You can watch OTLC and buy or sell other stocks, ETFs, and their options commission-free!About OTLC
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing.
OTLC Key Statistics
Stock Snapshot
With a market cap of 24.94M, Oncotelic Therapeutics(OTLC) trades at $0.05. The stock has a price-to-earnings ratio of 0.09.
As of 2026-05-15, Oncotelic Therapeutics(OTLC) stock has fluctuated between $0.04 and $0.05. The current price stands at $0.05, placing the stock +15.6% above today's low and -4.1% off the high.
Oncotelic Therapeutics(OTLC) shares are trading with a volume of 885.6K, against a daily average of 430.95K.
In the last year, Oncotelic Therapeutics(OTLC) shares hit a 52-week high of $0.11 and a 52-week low of $0.02.
In the last year, Oncotelic Therapeutics(OTLC) shares hit a 52-week high of $0.11 and a 52-week low of $0.02.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.